AstraZeneca PLC (NASDAQ:AZN)
| 65.84 Delayed Data As of Jan 30 |  +0.31 / +0.47%Today’s Change | 52.65 Today|||52-Week Range 72.12 | -2.89% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 65.53 |
| Today’s open | 66.38 |
| Day’s range | 65.72 - 66.40 |
| Volume | 249,453 |
| Average volume (3 months) | 5,571,131 |
| Market cap | $204.5B |
Data as of 4:00pm ET, 01/30/2023
Growth & Valuation
| Earnings growth (last year) | -96.76% |
| Earnings growth (this year) | +27.17% |
| Earnings growth (next 5 years) | +14.15% |
| Revenue growth (last year) | +37.11% |
| P/E ratio | 102.9 |
| Price/Sales | 4.39 |
| Price/Book | 5.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.01 | -0.01% |
| NVONovo Nordisk | +0.02 | +0.01% |
| PFEPfizer | -0.01 | -0.02% |
| BMYBristol-Myers Squibb | -0.42 | -0.58% |
Data as of 4:00pm ET, 01/30/2023
Financials
| Next reporting date | February 9, 2023 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $37.8B |
| Annual profit (last year) | $112.0M |
| Net profit margin | 0.30% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
